Retinopathy of Prematurity
Schedule
Your Appointment
What is Retinopathy of Prematurity?
Retinopathy of Prematurity (ROP) is a condition characterized by abnormal growth of blood vessels in the retina of premature infants who have undergone oxygen therapy. Screening guidelines for ROP are based on factors such as gestational age and birth weight, with early detection being crucial.
If left untreated, ROP can lead to childhood blindness. However, early treatment with interventions such as cryotherapy, laser photocoagulation, and anti-VEGF therapy has been shown to improve visual outcomes for affected infants.
Therefore, understanding ROP involves recognizing its risk factors, screening guidelines, and the importance of early treatment to prevent vision loss.
Symptoms
Treatments
Precautions
Symptoms
- Abnormal eye movements: Infants with ROP may display abnormal eye movements, such as rapid or jerky movements, which can be observed during eye examinations.
- Abnormal pupil reactions: Changes in pupil reactions, such as unequal pupil size or sluggish response to light, may be indicative of ROP.
- Strabismus (crossed eyes): Strabismus, where the eyes are misaligned and point in different directions, can be a symptom of advanced ROP.
- Poor vision or blindness: In severe cases of ROP, infants may experience poor vision or blindness due to retinal detachment or other complications affecting the visual pathway.
- White pupils (leukocoria): In some cases, leukocoria, or a white pupil, may be observed, which can indicate abnormalities in the retina, including ROP.
Treatments
- Observation: Type II ROP (zone I stage 1 or 2 without plus disease, or zone II stage 3 without plus disease) requires monitoring without treatment.
- Laser photocoagulation: Standard treatment involves argon or diode laser photocoagulation to ablate abnormal blood vessels and promote regression.
- Cryotherapy: Freezing the avascular retina helps induce regression of abnormal blood vessels, though laser photocoagulation is more commonly used now.
- Anti-VEGF therapy: Intravitreal bevacizumab aims to inhibit pathological angiogenesis, but concerns exist about late reactivation of ROP and systemic effects.
- Surgical intervention: Advanced stages (4A, 4B, 5) may require interventions like scleral buckling, vitrectomy, or lensectomy with vitrectomy to address retinal detachment. Success is evaluated based on anatomical and functional outcomes.
Precautions
- Early screening based on gestational age and birth weight to detect ROP promptly.
- Adopting a multidisciplinary approach from birth to childhood to identify and manage risk factors.
- Tailoring treatment based on the type of ROP, with Type I ROP usually requiring intervention.
- Considering surgical intervention for advanced stages, focusing on anatomical and functional success.
- Carefully evaluating treatment risks, especially with options like anti-VEGF therapy, to balance benefits and potential adverse effects.
Types of Retinopathy of Prematurity
Before Surgery
During the Surgery
After the Surgery
Before Surgery
- Patient Monitoring: Premature infants require careful monitoring, including pulse oximetry, neurologic screening, ultrasounds, and evaluation for conditions like bronchopulmonary dysplasia and patent ductus arteriosus.
- Postoperative Care Planning: Planning for post-surgery care is crucial, often involving mechanical or positive pressure ventilation, parenteral feeding, and antibiotic treatment.
- Vision Assessment and Management: Assessing vision and managing complications like amblyopia is vital, with therapy possibly including glasses, patching, or pharmacologic treatment.
- Nutrition and Infection Control: Ensuring optimal nutrition and infection control is essential, along with comprehensive neonatal care practices.
- Antenatal and Delivery Suite Interventions: Antenatal corticosteroids and delivery suite practices like delayed cord clamping may help reduce ROP complications.
During the Surgery
- Type of ROP: The decision to treat depends on the type of ROP, with Type I ROP requiring treatment and Type II ROP being observed.
- Surgical Techniques: Surgical treatment for ROP primarily involves cryotherapy or laser photocoagulation to the avascular retina, aiming to prevent retinal detachment and unfavorable outcomes.
- Use of Anti-VEGF Agents: In some cases, anti-VEGF agents like intravitreal bevacizumab may be used as a treatment strategy to reduce the risk of ROP recurrence.
- Monitoring for Complications: During surgery, particular attention is paid to potential complications such as retinal detachment, macular dragging, and late reactivation of ROP.
- Anesthesia and General Care: Given that ROP surgery often requires general anesthesia, ensuring proper anesthesia management and overall care of the premature infant during the procedure are critical.
After the Surgery
- Ventilation and Monitoring: Premature infants may need ventilation and close monitoring with pulse oximetry, neurologic screening, and ultrasounds to check for complications like bronchopulmonary dysplasia and patent ductus arteriosus.
- Nutrition and Antibiotics: Parenteral feeding and antibiotics may be necessary to support recovery.
- Long-term Vision Management: Managing amblyopia may involve glasses, patching, or pharmacologic treatment like atropine.
- Oxygen Therapy: Maintaining SpO2 targets of 90% to 94% helps prevent ROP complications.
- Continued Monitoring and Supportive Care: Ongoing monitoring, infection control, and pain management are crucial for neonatal care.
Retinopathy of Prematurity FAQs
Can ROP cause other complications?
Infants with ROP are at higher risk for developing other eye problems in the future, such as retinal detachment, myopia (nearsightedness), strabismus (crossed eyes), amblyopia (lazy eye), and glaucoma.
Fortunately, many of these eye problems can be treated.
How effective is ROP treatment?
Treatment for ROP can reduce the risk of vision loss, but unfortunately, some infants do not respond to ROP treatment, and retinal scarring or detachment can still occur— though usually only affecting part of the retina.
When a partial retinal detachment occurs, treatment is not always necessary, as it can resolve on its own without intervention. However, in some cases, treatment may be recommended to prevent a total retinal detachment that will require surgery to reattach the retina.
How common is ROP?
ROP affects over 3.5% of all premature births, as over 14,000 cases are diagnosed annually in the USA.
Approximately 3.9 million infants are born in the U.S. each year, with about 28,000 weighing in at 2¾ pounds or less at birth— but thanks to advances in neonatal care, not all premature infants develop ROP.
About 90% of all infants with ROP have a mild case, requiring no treatment at all, as it generally resolves on its own.
Will my child have lasting vision problems?
Premature infants are already more likely to have vision problems. Things like nearsightedness, crossed eyes, and glaucoma show up more often and earlier in children born prematurely. Regular eye exams can help catch these issues quickly.
Can ROP be prevented?
No one wants to give birth prematurely. Unfortunately, sometimes it can’t be prevented. We’ll do everything possible to limit factors we know can increase your baby’s risk of ROP.
For instance, we have fine control over how much oxygen we give with our machines.
But often, ROP will still occur. The best thing we can do is detect it early and treat it promptly.
Book Appointment
Call Us
